Patterns of genetic expression associated to sensibility to doxorubicin versus docetaxel as neoadjuvant chemotherapy for locally advanced breast cancer
Phase of Trial: Phase II
Latest Information Update: 01 Jul 2011
At a glance
- Drugs Docetaxel (Primary) ; Doxorubicin
- Indications Early breast cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 01 Jul 2011 Results published in Breast Cancer Research and Treatment.
- 11 Aug 2009 Actual end date (May 2009) added as reported by ClinicalTrials.gov.